MedPath
FDA Product

Metoprolol Succinate

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Metoprolol Succinate

72516-030

Regulatory Information

72516-030

ANDA207206

C73584

April 27, 2022

USA

These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. METOPROLOL succinate extended-release tablets USP, for oral useInitial U.S. Approval: 1992

HUMAN PRESCRIPTION DRUG LABEL

2

Company Information

080337493

Active Ingredients

METOPROLOL TARTRATE

Quantity: 25 mg in 1 1

Code: W5S57Y3A5L

Class Code: ACTIB

Inactive Ingredients

HYPROMELLOSE 2208 (4000 MPA.S)

Code: 39J80LT57T

Class Code: IACT

ETHYLCELLULOSE (10 MPA.S)

Code: 3DYK7UYZ62

Class Code: IACT

HYPROMELLOSE 2910 (5 MPA.S)

Code: R75537T0T4

Class Code: IACT

LECITHIN, SOYBEAN

Code: 1DI56QDM62

Class Code: IACT

CELLULOSE, MICROCRYSTALLINE

Code: OP1R32D61U

Class Code: IACT

POLYETHYLENE GLYCOL 4000

Code: 4R4HFI6D95

Class Code: IACT

TALC

Code: 7SEV7J4R1U

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

Active Moieties

METOPROLOL

Code: GEB06NHM23

© Copyright 2025. All Rights Reserved by MedPath